Trial NCT05008510

View at ClinicalTrials.gov 
Org. Study IDs: V2011801

Last trial update was posted on 2022-02-08

MeSH Interventions

Camptothecin Immunoconjugates Sacituzumab govitecan

MeSH Conditions

Breast Neoplasms Triple Negative Breast Neoplasms

Other Conditions

Metastatic Triple Negative Breast Cancer

Stopping Reasons

Decided to halt and will potentially reopen in the future.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID